The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/17982490

Oncogene 2008 Apr 10 27 17 2501-6

Download in:

View as

General Info

PMID
17982490